Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000721748-13-000473
Filing Date
2013-08-14
Accepted
2013-08-14 14:40:46
Documents
12
Period of Report
2011-11-30

Document Format Files

Seq Description Document Type Size
1 gbiq1111.htm 10-K 390119
2 EXHIBIT 32 ex32gbiq.htm EX-32 4871
3 CERTIFICATIONS ex311gbiq.htm EX-31.1 10207
4 CERTIFICATIONS ex312gbiq.htm EX-31.2 9604
11 GRAPHIC image_004.gif GRAPHIC 135
12 GRAPHIC image_005.gif GRAPHIC 73
  Complete submission text file 0000721748-13-000473.txt   3307970

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE gbiq-20111130.xml EX-101.INS 208357
6 XBRL SCHEMA FILE gbiq-20111130.xsd EX-101.SCH 20879
7 XBRL CALCULATION FILE gbiq-20111130_cal.xml EX-101.CAL 18817
8 XBRL DEFINITION FILE gbiq-20111130_def.xml EX-101.DEF 32482
9 XBRL LABEL FILE gbiq-20111130_lab.xml EX-101.LAB 133210
10 XBRL PRESENTATION FILE gbiq-20111130_pre.xml EX-101.PRE 112475
Mailing Address 2711 CENTERVILLE SUITE 400 WILMINGTON DE 19808
Business Address 2550 BATES RD. SUITE 212 MONTREAL A8 H3S 1A7 302 288 0658
Global Biotech Corp. (Filer) CIK: 0001126162 (see all company filings)

EIN.: 980229951 | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-33271 | Film No.: 131037134
SIC: 7389 Services-Business Services, NEC